Vultaggio Vincent 4

What Happened

• Vincent Vultaggio, listed as PAO and PFO at Zentalis Pharmaceuticals (ZNTL), sold a total of 40,224 shares in three transactions between Feb 6–10, 2026, for aggregate proceeds of about $97,557. These were dispositions (sales), not purchases.

Key Details

• Transactions:
  • 2026-02-06: 29,951 shares sold at $2.43 each — $72,772 (automatic sale to cover tax withholding on RSU vesting; footnote F1).
  • 2026-02-09: 3,379 shares sold at $2.39 each — $8,086 (sold under a Rule 10b5-1 plan; footnote F2).
  • 2026-02-10: 6,894 shares sold at $2.42 each — $16,699 (sold under the same 10b5-1 plan; footnote F2).
• Total shares sold: 40,224; total proceeds: approx. $97,557.
• Method: Reported as open market or private sales (Form 4 codes: S).
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Filing: Report filed Feb 10, 2026 covering transactions dated Feb 6–10, 2026 (see SEC Accession 0002018766-26-000006).

Context

• The Feb 6 sale was an automatic transfer by the issuer to satisfy tax withholding obligations tied to RSU vesting (routine tax-related disposition). The Feb 9 and Feb 10 sales were executed under a pre-established Rule 10b5-1 trading plan (planned dispositions).
• These are sales (routine/tax and plan-based); they do not necessarily indicate management’s view on company prospects.